CRSP Operating Expenses

Crispr Therapeutics Ag · Operating Expenses

CRSP logo

CRSP Operating Expenses

Latest reported$326.38M
CRSP Operating Expenses ($6.63M → $326.38M)
High-resolution chart · PNG

CRSP operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
338,869,000
391,316,000
462,288,000
563,347,000
438,375,000
85,747,000
63,488,000
162,067,000
105,645,000
73,294,000
25,976,000
6,627,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.